Patent directory · USPTO A61K / A61P
Patents matching “Rigel Pharmaceuticals, Inc.”
373 pharma patents match "Rigel Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 373 pharmaceutical patents matching "Rigel Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9255085
Carboxamide compounds and methods for using the same
granted -
US 9248132
Compositions and methods for inhibition of the JAK pathway
granted -
US 9248190
Compositions and methods for inhibition of the JAK pathway
granted -
US 9206161
Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
granted -
US 9181222
Protein kinase C inhibitors and uses thereof
granted -
US 9181220
N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
granted -
US 9174964
AMPK-activating piperidinyloxy-substituted 2,3-dihydro-1H-indene-1-amine compounds and pharmaceutical compositions including the same
granted -
US 9173882
Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
granted -
US 9169249
Protein kinase C inhibitors and uses thereof
granted -
US 9162989
2,4-Pyrimidinediamine compounds and their uses
granted -
US 9156820
Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
granted -
US 9149475
Protein kinase C inhibitors and uses thereof
granted -
US 9145433
GDF-8 inhibitors
granted -
US 9133133
2,4-pyridinediamine compounds and their uses
granted -
US 9096542
Kinase inhibitors and their uses
granted -
US 9095593
Protein kinase C inhibitors and uses thereof
granted -
US 9084795
Compositions and methods for inhibition of the JAK pathway
granted -
US 9079898
Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
granted -
US 9067925
Compositions and methods for inhibition of the JAK pathway
granted -
US 9062052
Carboxamide compounds and methods for using the same
granted -
US 9062068
Protein kinase C inhibitors and uses thereof
granted -
US 9040061
Topical formulation for administering a compound
granted -
US 9040527
Pyrimidinediamine kinase inhibitors
granted -
US 9040543
Compositions and methods for inhibition of the JAK pathway
granted